NLRP3 and immune system disorder: Decreased levels of IL-1β inhibit msu-induced activation of NLRP3 inflammatory vesicles, impede maturation and secretion of inflammatory cytokines, thereby reducing the recruitment of neutrophils and other cells and regulating immune disorders (Liu-Bryan et al., 2005; Bauernfeind et al., 2009).